Moderna
MRNA
79 hedge funds and large institutions have $2.01B invested in Moderna in 2018 Q4 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
633% more call options, than puts
Call options by funds: $22K | Put options by funds: $3K
40.61% more ownership
Funds ownership: 0% → 40.61% (+41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$966M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$281M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$251M |
| 4 |
AG
Artal Group
Luxembourg
|
+$86.4M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$78.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
SEI Investments
Oaks,
Pennsylvania
| $1K | +$13K | +790 | New |
|
77
Schroder Investment Management Group
London,
United Kingdom
| $916 | +$986K | +60,000 | New |
|
|
S
78
SignatureFD
Atlanta,
Georgia
| – | +$33 | +2 | New |
|
79
Group One Trading
Chicago,
Illinois
| – | +$378 | +23 | New |
|
MRNA Hedge Fund Activity: Q4 2018 in Review
79 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q4 2018, worth a combined $2.01B.
Buyers outnumbered sellers: 79 funds opened new MRNA positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Flagship Pioneering, opening a new position worth an estimated $966M.
- 79 institutional investors held Moderna (MRNA) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $2.01B of Moderna stock for Q4 2018.
- 79 funds opened new Moderna positions in Q4 2018 and 0 closed out, a net change of +79 holders.
- The largest Moderna buyer in Q4 2018 was Flagship Pioneering, an estimated $966M added.
Based on aggregated 13F filings for Q4 2018.